title: Interference of silver, gold, and iron oxide nanoparticles on epidermal growth factor signal transduction in epithelial cells.
abstract: Metallic nanomaterials, including silver, gold, and iron oxide, are being utilized in an increasing number of fields and specialties. The use of nanosilver as an antimicrobial agent is becoming ever-more common, whereas gold and iron oxide nanomaterials are frequently utilized in the medical field due to their recognized "biocompatibility". Numerous reports have examined the general toxicity of these nanomaterials; however, little data exists on how the introduction of these nanomaterials, at nontoxic levels, affects normal cellular processes. In the present study the impact of low levels of 10 nm silver (Ag-NP), gold (Au-NP), and iron oxide nanoparticles (SPION) on epidermal growth factor (EGF) signal transduction within the human epithelial cell line, A-431, was investigated. Following a biocompatibility assessment, the nanoparticle-induced interference at four specific targets within the EGF signaling process was evaluated: (1) nanoparticle-EGF association, (2) Akt and Erk phosphorylation, (3) Akt activity, and (4) EGF-dependent gene regulation. For all tested nanoparticles, following cellular exposure, a disruption in the EGF signaling response transpired; however, the metallic composition determined the mechanism of alteration. In addition to inducing high quantities of ROS, Ag-NPs attenuated levels of Akt and Erk phosphorylation. Au-NPs were found to decrease EGF-dependent Akt and Erk phosphorylation as well as inhibit Akt activity. Lastly, SPIONs produced a strong alteration in EGF activated gene transcription, with targeted genes influencing cell proliferation, migration, and receptor expression. These results demonstrate that even at low doses, introduction of Ag-NPs, Au-NPs, and SPIONs impaired the A-431 cell line's response to EGF.
authors: Molecular Bioeffects Branch, Human Effectiveness Directorate, Air Force Research Laboratory, Wright-Patterson ABF, Ohio 45433, United States.
authors: Kristen K
authors: KK
authors: Comfort
authors: Elizabeth I
authors: EI
authors: Maurer
authors: Laura K
authors: LK
authors: Braydich-Stolle
authors: Saber M
authors: SM
authors: Hussain
mesh_terms: D002460:Cell Line; D004815:Epidermal Growth Factor / Q000378:metabolism*; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism*; D005290:Ferric Compounds / Q000494:pharmacology*; D006046:Gold / Q000494:pharmacology*; D006801:Humans; D053758:Nanoparticles / Q000008:administration & dosage*; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology*; D012834:Silver / Q000494:pharmacology*
chemical_list: D005290:Ferric Compounds; C000499:ferric oxide; D012834:Silver; D004815:Epidermal Growth Factor; D006046:Gold